Nurix Therapeutics Inc (NRIX) — Defensive Interval Ratio
Nurix Therapeutics Inc (NRIX) has a Defensive Interval Ratio of 1561 days as of August 2025. Defensive assets of $352.09 Million (cash $-, short-term investments $350.39 Million, receivables $1.70 Million) cover 1561 days of daily cash needs of $225.62K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Nurix Therapeutics Inc Defensive Interval Ratio (2018–2024)
This chart shows how Nurix Therapeutics Inc's Defensive Interval Ratio has evolved across 7 annual periods from 2018 to 2024. As of August 2025, the ratio stands at 1561 days, meaning defensive assets of $352.09 Million can fund 1561 days of operations without new revenue. For the complete balance sheet picture, see balance sheet size of Nurix Therapeutics Inc.
Annual Defensive Interval Ratio for Nurix Therapeutics Inc (2018–2024)
The table below presents the year-by-year Defensive Interval Ratio for Nurix Therapeutics Inc from 2018 to 2024, covering 7 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See Nurix Therapeutics Inc current assets vs equity to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1908 days | $501.09 Million | $262.61K/day | $- | $499.59 Million | ▲ +926 days |
| 2023 | 983 days | $234.08 Million | $238.24K/day | $- | $233.28 Million | ▼ -287 days |
| 2022 | 1270 days | $245.77 Million | $193.58K/day | $- | $244.67 Million | ▲ +50 days |
| 2021 | 1220 days | $221.42 Million | $181.53K/day | $- | $215.21 Million | ▼ -199 days |
| 2020 | 1419 days | $173.14 Million | $122.02K/day | $- | $161.79 Million | ▲ +1353 days |
| 2019 | 66 days | $2.90 Million | $44.21K/day | $- | $2.90 Million | ▼ -84 days |
| 2018 | 150 days | $13.45 Million | $89.95K/day | $- | $13.45 Million | — |